Daniil Gataulin
Stock Analyst at Chardan Capital
(4.83)
# 91
Out of 5,005 analysts
114
Total ratings
62.14%
Success rate
56.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $11.14 | +88.51% | 2 | Oct 2, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $4.00 | +150.00% | 2 | Sep 30, 2025 | |
| QURE uniQure | Maintains: Buy | $35 → $76 | $55.41 | +37.17% | 8 | Sep 25, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.75 | +301.15% | 14 | Sep 19, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $70 → $48 | $47.88 | +0.26% | 4 | Sep 10, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $10.75 | +383.72% | 13 | Sep 8, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $1.10 | +173.97% | 10 | Aug 28, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $15.10 | +303.92% | 6 | Aug 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.42 | +315.68% | 5 | Aug 15, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $5.38 | +513.38% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $8.68 | +72.81% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.50 | +166.67% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $13.64 | +97.95% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.45 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $18.04 | +82.93% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.62 | +35,418.24% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.57 | - | 2 | Jul 25, 2023 |
Ocular Therapeutix
Oct 2, 2025
Maintains: Buy
Price Target: $21
Current: $11.14
Upside: +88.51%
Zura Bio
Sep 30, 2025
Maintains: Buy
Price Target: $10
Current: $4.00
Upside: +150.00%
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $35 → $76
Current: $55.41
Upside: +37.17%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.75
Upside: +301.15%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $70 → $48
Current: $47.88
Upside: +0.26%
REGENXBIO
Sep 8, 2025
Maintains: Buy
Price Target: $52
Current: $10.75
Upside: +383.72%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $1.10
Upside: +173.97%
Forte Biosciences
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $15.10
Upside: +303.92%
MeiraGTx Holdings
Aug 15, 2025
Maintains: Buy
Price Target: $35
Current: $8.42
Upside: +315.68%
Adverum Biotechnologies
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $5.38
Upside: +513.38%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.68
Upside: +72.81%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.50
Upside: +166.67%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $13.64
Upside: +97.95%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.45
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $18.04
Upside: +82.93%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.62
Upside: +35,418.24%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.57
Upside: -